ERC-PoC-2014
ERC-PoC-2014
Programme: H2020
121 projects · €17,992,183 total EU contribution (project-level) · 88 participating organizations · 18 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€17,992,183
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (15)
- Netherlands (12)
- Spain (10)
- Germany (9)
- Italy (9)
- France (7)
- IL (6)
- FI (4)
- IE (4)
- CH (2)
- CY (2)
- SE (2)
- BE (1)
- DK (1)
- EL (1)
- IS (1)
- NO (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- WEIZMANN7 projects · IL
- CNRS5 projects · FR
- CSIC4 projects · ES
- STICHTING VU4 projects · NL
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY4 projects · IL
- UOXF4 projects · UK
- BIU3 projects · IL
- CIMNE-CERCA3 projects · ES
- KTH3 projects · SE
- TRDF LTD3 projects · IL
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3 projects · UK
- THE HEBREW UNIVERSITY OF JERUSALEM3 projects · IL
Projects
Page 8 of 13
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
A potent Micro-RNA therapeutic for nonalcoholic fatty liver disease (NAFLD) FLDcure · 639314 | H2020 | €149,800 | €149,800 | Details |
Silencing miR-199b to attenuate the progression of heart failure. SIRENE · 665647 | H2020 | €150,000 | €150,000 | Details |
A Non-Invasive Test for Guiding Follow–up of Patients with CT-Detected Lung Nodules LuMaSense · 636335 | H2020 | €150,000 | €150,000 | Details |
Development of pregnenolone derivatives as allosteric inhibitors of CB1 cannabinoid receptors for the treatment of schizophrenia and psychotic syndromes CannaPreg · 640923 | H2020 | €150,000 | €150,000 | Details |
Photon Cross Correlation Spectroscopy PHOCCS · 664738 | H2020 | €149,984 | €149,984 | Details |
Morphogenetically active blood vessels: Proof-of-Concept MorphoVES-PoC · 662486 | H2020 | €149,962 | €149,962 | Details |
CHIRALSENSE : Sensing Chirality using cavity-enhanced polarimetry: advances in sensitivity and time-resolution CHIRALSENSE · 665770 | H2020 | €150,000 | €150,000 | Details |
Low Temperature Ceramics Applications LTCeramics · 640887 | H2020 | €150,000 | €150,000 | Details |
Flow Visualization Based Pressure FLOVISP · 665477 | H2020 | €148,750 | €126,375 | Details |
Sequence-Enabled Single cEll Identification device SENSEI · 641389 | H2020 | €150,000 | €150,000 | Details |